Chronic fatigue syndrome: characteristics and possible causes for its pathogenesis.

Chronic fatigue syndrome is a heterogeneous disorder with unknown pathogenesis and etiology, characterized by disabling fatigue, difficulty in concentration and memory, and concomitant skeletal and muscular pain. Several mechanisms have been suggested to play a role in CFS, such as excessive oxidative stress following exertion, immune imbalance characterized by decreased natural killer cell and macrophage activity, immunoglobulin G subclass deficiencies (IgG1, IgG3) and decreased serum concentrations of complement component. Autoantibodies were also suggested as a possible factor in the pathogenesis of CFS. Recent studies indicate that anti-serotonin, anti-microtubule-associated protein 2 and anti-muscarinic cholinergic receptor 1 may play a role in the pathogenesis of CFS. It has been demonstrated that impairment in vasoactive neuropeptide metabolism may explain the symptoms of CFS.

[1]  J. Fostel,et al.  Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. , 2006, Pharmacogenomics.

[2]  H. Zenner,et al.  Häufigkeit und klinische Relevanz von Antikörpern gegen Phospholipide, Serotonin und Ganglioside bei Patienten mit Hörsturz und progredienter Innenohrschwerhörigkeit , 1998, HNO.

[3]  J P Kehrer,et al.  Oxidative stress and muscular dystrophy. , 1989, Chemico-biological interactions.

[4]  T. Takano,et al.  Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. , 2003, International journal of molecular medicine.

[5]  M. Tsang,et al.  Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. , 1991, Cytokine.

[6]  D. Buchwald,et al.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. , 1996, The Journal of clinical investigation.

[7]  L. Robins,et al.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. , 1981, Archives of general psychiatry.

[8]  B K Pedersen,et al.  Chronic fatigue syndrome--a controlled cross sectional study. , 1994, The Journal of rheumatology.

[9]  C. Schenck,et al.  Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. , 1994, Clinical and diagnostic laboratory immunology.

[10]  H. Golden.  Clinical laboratory test findings in patients with chronic fatigue syndrome. , 1995, Archives of internal medicine.

[11]  S. Claes,et al.  Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue Syndrome , 2007, Neuropsychobiology.

[12]  Elizabeth R. Unger,et al.  Utility of the Blood for Gene Expression Profiling and Biomarker Discovery in Chronic Fatigue Syndrome , 2003, Disease markers.

[13]  C. Dinarello,et al.  Circulating lymphokine levels in the chronic fatigue syndrome. , 1989, The Journal of infectious diseases.

[14]  W. Reeves,et al.  Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome , 2005, Journal of autoimmune diseases.

[15]  H. Hashimoto,et al.  Neuroprotective action of endogenous PACAP in cultured rat cortical neurons , 2005, Regulatory Peptides.

[16]  H. Zenner,et al.  [Incidence and clinical relevance of antibodies to phospholipids, serotonin and ganglioside in patients with sudden deafness and progressive inner ear hearing loss]. , 1998, HNO.

[17]  S. Fulle,et al.  Modification of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome , 2003, Neuromuscular Disorders.

[18]  Simon Wessely,et al.  Chronic Fatigue Syndrome , 1996, BMJ : British Medical Journal.

[19]  R. Wheatland.  Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. , 2005, Medical hypotheses.

[20]  P. Manu,et al.  Definition of the chronic fatigue syndrome. , 1988, Annals of internal medicine.

[21]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[22]  R. Klein,et al.  High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. , 1995, European journal of medical research.

[23]  J. Ribas,et al.  Kinetics of plasma potassium concentrations during exhausting exercise in trained and untrained men , 2004, European Journal of Applied Physiology and Occupational Physiology.

[24]  R. Patarca,et al.  Cytokines and Chronic Fatigue Syndrome , 2001, Annals of the New York Academy of Sciences.

[25]  W. Reeves,et al.  The epidemiology of chronic fatigue in San Francisco. , 1998, The American journal of medicine.

[26]  Joab Chapman,et al.  Infection and vaccination in chronic fatigue syndrome: Myth or reality? , 2007, Autoimmunity.

[27]  Rosane Nisenbaum,et al.  Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome , 2003, Journal of Translational Medicine.

[28]  M. Nishikai.  [Antinuclear antibodies in patients with chronic fatigue syndrome]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[29]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[30]  C. Schenck,et al.  Chronic fatigue syndrome in Minnesota. , 1991, Minnesota medicine.

[31]  S T Holgate,et al.  Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome , 2005, Journal of Clinical Pathology.

[32]  D. Buchwald,et al.  High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. , 1997, Arthritis and rheumatism.

[33]  B. Natelson,et al.  Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations. , 2001, The Journal of rheumatology.

[34]  Frank Emmert-Streib,et al.  The Chronic Fatigue Syndrome: A Comparative Pathway Analysis , 2007, J. Comput. Biol..

[35]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.